Tyra Biosciences Inc TYRA

NAS: TYRA | ISIN: US90240B1061 3/05/2024

17,85 USD (-3,67%)

(-3,67%) 3/05/2024

Grafiek Tyra Biosciences Inc

Grafiek Tyra Biosciences Inc

1 dag1d -3,67%
1 week1w 8,51%
1 maand1m 4,39%
3 maanden3m -0,83%
6 maanden6m 39,45%
1 jaar1j 32,22%
5 jaar5j -31,35%

Tyra Biosciences Inc in het nieuws

Toon enkel gratis nieuws

19 maart 2024 · Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights · Persbericht

27 februari 2024 · Tyra Biosciences to Present at Upcoming Investor Conferences · Persbericht

7 februari 2024 · Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference · Persbericht

2 februari 2024 · Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing · Persbericht

1 februari 2024 · Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia · Persbericht

22 december 2023 · Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300 · Persbericht

8 november 2023 · Tyra Biosciences to Participate in 2023 Jefferies London Healthcare Conference · Persbericht

7 november 2023 · Tyra Biosciences Reports Third Quarter 2023 Financial Results and Highlights · Persbericht

21 september 2023 · Tyra Biosciences Announces Oral Presentations on TYRA-300 for Achondroplasia at the ASBMR and ASHG 2023 Annual Meetings · Persbericht

12 september 2023 · Tyra Biosciences to Participate at 2023 Cantor Global Healthcare Conference · Persbericht

Profiel Tyra Biosciences Inc

Werknemers: 34

Aandelen Tyra Biosciences Inc

Beurswaarde: 937,55 miljoen USD

Effecten: 52,52 miljoen

Beta: 1,82

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe